Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR4 | P22455 | 15/20 | 0.70 |
| ▸ | FGFR1 | P11362 | 4/20 | 0.70 |
| ▸ | RET | P07949 | 4/20 | 0.70 |
| ▸ | FGFR2 | P21802 | 3/20 | 0.70 |
| ▸ | FGFR3 | P22607 | 3/20 | 0.70 |
| ▸ | KDR | P35968 | 3/20 | 0.70 |
| ▸ | PDGFRB | P09619 | 3/20 | 0.70 |
| ▸ | PDGFRA | P16234 | 3/20 | 0.70 |
| ▸ | KIT | P10721 | 2/20 | 0.70 |
| ▸ | FLT1 | P17948 | 2/20 | 0.70 |
| ▸ | FLT4 | P35916 | 2/20 | 0.70 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.70 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.70 |
| ▸ | ERN1 | O75460 | 1/20 | 0.70 |
| ▸ | STK10 | O94804 | 1/20 | 0.70 |
| ▸ | MAP3K6 | O95382 | 1/20 | 0.70 |
| ▸ | ABL1 | P00519 | 1/20 | 0.70 |
| ▸ | ESR1 | P03372 | 1/20 | 0.70 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.70 |
| ▸ | BCR | P11274 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12412325 | 0.93 | FGFR4 (0.59) | FGFR4FGFR1RETFGFR2FGFR3 | |
| SCHEMBL13613075 | 0.92 | FGFR4 (0.58) | FGFR4FGFR1RETFGFR2FGFR3 | |
| SCHEMBL12673672 | 0.92 | FGFR4 (0.58) | FGFR4FGFR1RETFGFR2FGFR3 | |
| SCHEMBL12412326 | 0.92 | FGFR4 (0.57) | FGFR4FGFR1RETFGFR2FGFR3 | |
| SCHEMBL1894530 | 0.90 | FGFR4 (0.56) | FGFR4FGFR1RETFGFR2FGFR3 | |
| SCHEMBL12412082 | 0.90 | FGFR4 (0.56) | FGFR4FGFR1RETFGFR2FGFR3 | |
| SCHEMBL1889240 | 0.90 | FGFR4 (0.76) | FGFR4FGFR1RETFGFR2FGFR3 | |
| SCHEMBL1895420 | 0.89 | FGFR4 (0.83) | FGFR4FGFR1RETFGFR2FGFR3 | |
| SCHEMBL22505756 | 0.87 | FGFR4 (0.75) | FGFR4FGFR1RETFGFR2FGFR3 | |
| SCHEMBL12412367 | 0.87 | FGFR4 (0.51) | FGFR4FGFR1RETFGFR2FGFR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8372981-B2 | Nitrogen-containing aromatic derivatives | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2013-02-12 | — | — | US | disclosed |
| US-7973160-B2 | Nitrogen-containing aromatic derivatives | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2011-07-05 | — | — | US | disclosed |
| US-20100197911-A1 | Nitrogen-Containing Aromatic Derivatives | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2010-08-05 | — | — | US | disclosed |
| US-7253286-B2 | Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective | EISAI CO., LTD (JP) | 2007-08-07 | — | — | US | disclosed |
| US-7253286-B2 | Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective | EISAI CO., LTD (JP) | 2007-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197911-A1 | Nitrogen-Containing Aromatic Derivatives | GNG2, GCG, FRG1 | FGFR4 2049/4885FGFR1 499/4885RET 1840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.